Anticoagulation Software

 

 

Latest News

Version 7 Sampler E-Book

Why Computer Aided   Dosing is so important!

How does the Computer Manage Doses ?

What our Customers Say!

Why Buy Dawn AC?

Existing Customer List

Why Customers Chose Dawn AC

Your Key Objectives

Success Factors

Benefit/Cost Statement

Version 6 Structure

Newsletter

Audit and Benchmarking

 

E-Newsletter September 2006

Topics in this Dawn AC E-Newsletter              Previous Newsletters

 DAWN AC Anticoagulation Software E-Newsletter
  September 2006 
  IN THIS ISSUE
 
  • 2006 User Group
  • Migrate to V7
  • SW Symposium
  • Low occult bleeding
  • Elderly at risk 
  •  

    Welcome to Dawn AC September 2006 edition of the DAWN AC Anticoagulation Software E-Newsletter.
     
    We have lots to tell you this month including an invite to an symposium in Albuquerque later on this month.
     
     2006 User Group...
    ... Was a huge success for the fourteenth time running!
     
    All of the talks were excellent. Our special thanks to the speakers. 
     
    I am delighted to discover from the feedback surveys, that every one of you that attended said you would come again and that the hotels, meals and conference centre were up to a good standard for all of you.
     
    "The best meeting ever" was a common comment.
     
    I am also pleased to hear that you all enjoyed the steamer boat ride so much, I was relieved to see people net working so well and that the rain held off until right at the end.
     
    I hope to put the talk write ups and presentations on our website in the coming weeks.
     
    I look forward to seeing you all there next year!
     
     Migrate to V7
    Many of you have had quotations for upgrading to v7 we are now pleased to announce that because of improved processes the costs for this have been reduced. Please call us for an updated quote.
     
    Remember Dawn AC v7 has been completely and carefully redesigned, using advanced design methodologies, for the frequent user. It has a patent pending colour coding system and display to give an outstandingly easy to use, comprehensive and safe interface. It continues to be based on the proven proprietary Dawn AC dosage adjustment algorithm. 
    • Is highly configurable so that customers achieve the highest levels of fitness of purpose to meet their local practice.
    • It works with most common browsers to give outstanding response time performance and reliability. It has the capacity to handle district-wide, regional or even national systems.
    • Ability to interface other healthcare software systems using HL7 protocols to facilitate integration with coexisting centralised electronic medical record and laboratory systems.
    • A powerful messaging capability is provided to handle all types of events e.g. High INRs, so that all parties are appropriately informed by telephone, email, SMS, or mail.
    Customers who have had a preview of the system have given an extremely positive response and are so excited by the concepts in this new product design. 
     SW Symposium on Thrombosis
     
    South West Symposium on Thrombosis and Hemostasis,
    Albuquerque, New Mexico, 13-14th October 2006
     

    If you are attending the above symposium, I invite you to come and visit our booth. I would like to show you how our Dawn AC anticoagulation software can boost safety and productivity.  

    If you are unable to attend the symposium, but would still like some information on our product and services then please do not hesitate to contact us as we will be happy to arrange an internet demonstration for you.

     

    We hope to see you there!  

     

     Low Occult Bleeding
    Low occult bleeding levels with aspirin, warfarin use in post-MI patients.
     
    The use of aspirin, warfarin, or both drugs by patients after myocardial infarction (MI) does not appear to result in significant levels of occult bleeding with anemia or iron deficiency.
     
    In general, only macroscopic bleedings during treatment with these antithrombotic drugs are of clinical relevance, and that screening for occult bleeding yields limited further information. These findings perhaps go some way to allay anxieties over bleeding with the use or abuse of anticoagulant therapies. 
     
    To read the rest of this article please follow the link below:
     Elderly at Risk of Drug Errors
    695 people aged 78 to 86 living in sheltered housing were surveyed and it revealed half were taking more than five different medicines a day. Some 14% of the sample were using highly toxic medications such as warfarin.
     
    The risk of making mistakes was increased by frequent changes in elderly people's medication routines.
     
    The article suggests that Pharmacists could help ensure patients were taking their drugs properly by carrying out medication reviews.
     
    To read the rest of this article please follow the link below:
     
     
     © 2006 4S Information Systems Ltd
    Phone: +44 (0) 15395 63091